Clinical Pharmacology Research Unit (CPU)

Clinical Pharmacology Unit (CPU)

Characteristics:

The Clinical Pharmacology Unit is a specialized clinical department to perform clinical trials in early as well as late phases of the development of medicinal products and medical devices. Our department with a capacity of 24 (alternatively 28) beds is equipped to provide pharmacokinetic and bioequivalence studies, phase I, I/II studies with medicinal substances and/or medical devices. In cooperation with other departments of Thomayer Hospital, trials of later stages (phase II/III) can also be performed directly in CPU. In some cases, our unit serves as a coordinator of clinical trials performed in other hospital departments (offering project management, technical support, and logistics while also providing clinical services (nurses trained in Good Clinical Practice, investigators participating in study on-site visits). In any case, CPU secures that the high quality standards will be applied and maintained. CPU has been repeatedly inspected by the Czech regulatory authority (State Institute for Drug Control) and sponsors, and was found to be compliant with GCP standards. CPU has also been certified to conduct drug and device phase I-IV trials under ISO 9001/2008 (2010, confirmed by audits in 2011 and 2012).

Head of the Department
Jiří Škopek, MD, PhD.
tel.: 776 710 825
jiri.skopek@ftn.cz

Contact for English-speaking guests

tel.: 261 083 597,
       776 710 825
jiri.skopek@ftn.cz

Location

building B5

Map